Abstract
The study aimed to examine the role of patient education about biosimilar medicines, by looking at 1) what kind of information is needed for patients, 2) which information is already available, and 3) how to efficiently reach the patient.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
